Z-Gly-Gly-Arg-AMC TFA (66216-78-2 free base)

Download Files:

Z-Gly-Gly-Arg-AMC TFA (66216-78-2 free base)

SKU T8556-1 mL * 10 mM (in DMSO) Category Peptide Brand: TargetMol

Price range: 128 CAD through 1,808 CAD

For Research Use Only (RUO). This product is sold strictly for laboratory research use. Not for human or veterinary consumption, therapeutic, or diagnostic use.For sale to research organizations and laboratories only; not for patients or for personal use.

Size

1 mg 1 mL * 10 mM (in DMSO)10 mg 100 mg 200 mg 25 mg 5 mg 50 mg

Clear

Products Details

Product Description

– Z-Gly-Gly-Arg-AMC TFA (66216-78-2 free base) is a thrombin-specific fluorogenic substrate used to assess thrombin generation in platelet-rich plasma (PRP) and platelet-poor plasma (PPP).

For Research Use Only (RUO). This product is sold strictly for laboratory research use only. Not for human or veterinary consumption, therapeutic, or diagnostic use. Any pharmacological, therapeutic, cosmetic, or biological effects described above are provided as research context only and do not represent intended or approved uses of this product.

Web ID

– T8556

Storage Temperature

– -20℃

Shipping

– Blue Ice

Molecular Formula

– C30H34F3N7O9

References

– Ivan D Tarandovskiy, Elena O Artemenko, Mikhail A Panteleev,et al.Antiplatelet agents can promote two-peaked thrombin generation in platelet rich plasma: mechanism and possible applications.PLoS One. 2013;8(2):e55688.

CAS Number

– 66216-79-3

Molecular Weight

– C30H34F3N7O9

Compound Purity

– 0.9977

SMILES

– CC(C1=CC=C(NC([C@H](CCCNC(N)=N)NC(CNC(CNC(OCC2=CC=CC=C2)=O)=O)=O)=O)C=C1O3)=CC3=O.OC(C(F)(F)F)=O

Pathway

– Others

Product type

– Peptide

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.